Plain language summary of the CARTITUDE-4 study of ciltacabtagene autoleucel for the treatment of people with relapsed or refractory multiple myeloma

  1. San-Miguel, J.
  2. Dhakal, B.
  3. Patel, N.
  4. Schecter, J.M.
  5. Lendvai, N.
  6. Einsele, H.
Journal:
Future Oncology

ISSN: 1744-8301,  1479-6694

Year of publication: 2024

Volume: 20

Issue: 33

Pages: 2509-2520

Type: Article

DOI: 10.1080/14796694.2024.2376973 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals

Data source: Scopus